Sharps Stock (NASDAQ:STSS)

Revenue Ownership Financials Chart

Previous Close

$2.84

52W Range

$2.34 - $18.15

50D Avg

$4.21

200D Avg

$5.95

Market Cap

$5.31M

Avg Vol (3M)

$75.67K

Beta

1.17

Div Yield

-

STSS Company Profile

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

57

IPO Date

Apr 14, 2022

Website

STSS Performance

STSS Financial Summary

	Dec 23	Dec 22	Dec 21
Revenue	-	-	-
Operating Income	$-10.13M	$-8.74M	$-4.50M
Net Income	$-9.84M	$779.88K	$-4.83M
EBITDA	$-9.24M	$-13.50M	$-4.47M
Basic EPS	$-0.76	$0.10	$-0.99
Diluted EPS	$-0.76	$0.10	$-0.99

Fiscal year ends in Dec 23 | Currency in USD

Peer Comparison

Ticker	Company
ZJYL	Jin Medical International Ltd.
AVGR	Avinger, Inc.
GMVD	G Medical Innovations Holdings Ltd
KRMD	KORU Medical Systems, Inc.
GCTK	GlucoTrack, Inc.
MBOT	Microbot Medical Inc.
POCI	Precision Optics Corporation, Inc.
MHUA	Meihua International Medical Technologies Co., Ltd.
LUCY	Innovative Eyewear, Inc.
NXGL	NEXGEL, Inc.
UTMD	Utah Medical Products, Inc.